Andy Acker
Andy Acker
Andy Acker is a portfolio manager at Janus Henderson Investors responsible for managing the global life sciences and biotechnology strategies since 2007 and 2018, respectively. He also leads the firm’s health care sector research team. Andy received his bachelor of science degree in biochemical sciences from Harvard University, graduating magna cum laude and Phi Beta Kappa. He also earned an MBA with honours from Harvard Business School. Andy holds the Chartered Financial Analyst designation and has 26 years of financial industry experience.

Headwinds are starting to abate with a permanent FDA commissioner installed, uncertainty around drug-pricing reform set to ease and a cash-rich biopharma industry eyeing up biotech’s low valuations.

Related Topic